CCN1 and Miyoshi myopathy: In contrast to this, Johnson (Johnson et al. 2014) reported that recombinant CCN1 decreased the growth of a MM cell line at high concentrations and overexpression of CCN1 in MM cells reduced tumour growth, inhibited osteoclastogenesis and stimulated osteoblastogenesis in a mouse model of MM.